X4 Pharmaceuticals, Inc. (XFOR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 169.17M |
| Enterprise Value | 29.41M |
| P/E Ratio | -3.37 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 24.05 |
| Price/Book Ratio | 3.28 |
| Enterprise/Revenue | 16.61 |
| Enterprise/EBITDA | -3.31 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -5.69 |
| Operating Margin | -5.55 |
| Return On Assets | -0.36 |
| Return On Equity | -0.63 |
| Revenue | 35.11M |
| Revenue/Share | 0.13 |
| Gross Profit | 28.86M |
| EBITDA | -69.01M |
| Net Income | -79.2M |
| Diluted EPS | -1.87 |
| Total Cash | 207.97M |
| Total Cash/Share | 1.65 |
| Total Debt | 77.22M |
| Total Debt/Equity | 0.5 |
| Current Ratio | 11.3 |
| Book Value Per Share | 1.23 |
| 52-Week Change | 3.06 |
| 52-Week High | 4.83 |
| 52-Week Low | 2.8 |
| Moving Average 50 Days | 4.07 |
| Moving Average 200 Days | 3.92 |
| Average Volume | 774,080 |
| Shares Outstanding | 94.32M |
| % Held by Institutions | 71.61 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | April 28, 2025 |